CoChat

p21 promotes error-free replication-coupled DNA double-strand break repair

Open access

The DOI matches its Crossref record; 38 of the 41 references it cites were found in a registry or an index.

Abstract

p21 is a well-established regulator of cell cycle progression. The role of p21 in DNA repair, however, remains poorly characterized. Here, we describe a critical role of p21 in a replication-coupled DNA double-strand break (DSB) repair that is mechanistically distinct from its cell cycle checkpoint function. We demonstrate that p21-deficient cells exhibit elevated chromatid-type aberrations, including gaps and breaks, dicentrics and radial formations, following exposure to several DSB-inducing agents. p21-/- cells also exhibit an increased DNA damage-inducible DNA-PKCS S2056 phosphorylation, indicative of elevated non-homologous DNA end joining. Concomitantly, p21-/- cells are defective in replication-coupled homologous recombination (HR), exhibiting decreased sister chromatid exchanges and HR-dependent repair as determined using a crosslinked GFP reporter assay. Importantly, we establish that the DSB hypersensitivity of p21-/- cells is associated with increased cyclin-dependent kinase (CDK)-dependent BRCA2 S3291 phosphorylation and MRE11 nuclear foci formation and can be rescued by inhibition of CDK or MRE11 nuclease activity. Collectively, our results uncover a novel mechanism by which p21 regulates the fidelity of replication-coupled DSB repair and the maintenance of chromosome stability distinct from its role in the G1-S phase checkpoint.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/nar/gks612

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Functional requirement for p21 in the cellular response to the DNA crosslinking agent mitomycin C. (A–C) p21+/+ and p21−/− MEFs were incubated in the absence or presence of 25 and 50 nM MMC for 18 h, and the numbers of chromosome gaps and breaks (A), and complex chromosome aberrations (B), including dicentric chromosomes and radial formations, were scored. At least 50 metaphases were scored per treatment. (C) Representative chromosome aberrations detected in p21−/− MEFs. Arrows point to radial chromosomes; arrowheads point to chromatid fusions. (D–F) HeLa cells were transfected with control, non-targeting (siCtrl) and p21 (sip21) siRNAs. Fifty-four hours post-transfection, cells were incubated in the absence or presence of 50 and 100 nM MMC for 16 h. (D) Whole-cell lysates were prepared, and resolved proteins were immunoblotted with anti-p21 and anti-α-tubulin antibodies. The asterisk denotes a non-specific band. (E and F) Metaphase spreads were prepared, and chromosome gaps and breaks (E) and complex chromosome aberrations (F) were scored. (G–I) HCT116 p21−/− cells were transiently transfected with pLenti6.2-p21 or pLenti6.2-lacZ and treated with 0, 10 and 20 nM MMC for 16 h. (G) Whole-cell lysates were prepared, and resolved proteins were immunoblotted with anti-p21 and anti-α-tubulin antibodies. The asterisk denotes a non-specific band. (H and I) Metaphase spreads were prepared, and chromosome gaps and breaks (H) and complex chromosome aberrations (I), including dicentric chromosomes and radial formations, were scored. At least 80 metaphases were scored per treatment. Error bars represent the standard errors of the means from independent experiments. *P < 0.05; **P < 0.01; ***P < 0.001.
Figure 1. Functional requirement for p21 in the cellular response to the DNA crosslinking agent mitomycin C. (A–C) p21+/+ and p21−/− MEFs were incubated in the absence or presence of 25 and 50 nM MMC for 18 h, and the numbers of chromosome gaps and breaks (A), and complex chromosome aberrations (B), including dicentric chromosomes and radial formations, were scored. At least 50 metaphases were scored per treatment. (C) Representative chromosome aberrations detected in p21−/− MEFs. Arrows point to radial chromosomes; arrowheads point to chromatid fusions. (D–F) HeLa cells were transfected with control, non-targeting (siCtrl) and p21 (sip21) siRNAs. Fifty-four hours post-transfection, cells were incubated in the absence or presence of 50 and 100 nM MMC for 16 h. (D) Whole-cell lysates were prepared, and resolved proteins were immunoblotted with anti-p21 and anti-α-tubulin antibodies. The asterisk denotes a non-specific band. (E and F) Metaphase spreads were prepared, and chromosome gaps and breaks (E) and complex chromosome aberrations (F) were scored. (G–I) HCT116 p21−/− cells were transiently transfected with pLenti6.2-p21 or pLenti6.2-lacZ and treated with 0, 10 and 20 nM MMC for 16 h. (G) Whole-cell lysates were prepared, and resolved proteins were immunoblotted with anti-p21 and anti-α-tubulin antibodies. The asterisk denotes a non-specific band. (H and I) Metaphase spreads were prepared, and chromosome gaps and breaks (H) and complex chromosome aberrations (I), including dicentric chromosomes and radial formations, were scored. At least 80 metaphases were scored per treatment. Error bars represent the standard errors of the means from independent experiments. *P < 0.05; **P < 0.01; ***P < 0.001.CC BY-NC · PubMed Central
Figure 2. p21−/− cells are hypersensitive to the clastogenic effects of etoposide and camptothecin. (A–C) HCT116 p21+/+ and p21−/− cells were treated with 0.2 and 0.5 µM etoposide (VP-16) for 16 h and chromosome gaps and breaks (A), dicentric chromosomes (B) and complex chromosome aberrations (C) were scored. (D–F) p21+/+ and p21−/− cells were treated with 0.4 and 0.8 nM CPT, and chromosome gaps and breaks (D), dicentric chromosomes (E) and complex chromosome aberrations (F) were scored. *P < 0.05; **P < 0.01; ***P < 0.001.
Figure 2. p21−/− cells are hypersensitive to the clastogenic effects of etoposide and camptothecin. (A–C) HCT116 p21+/+ and p21−/− cells were treated with 0.2 and 0.5 µM etoposide (VP-16) for 16 h and chromosome gaps and breaks (A), dicentric chromosomes (B) and complex chromosome aberrations (C) were scored. (D–F) p21+/+ and p21−/− cells were treated with 0.4 and 0.8 nM CPT, and chromosome gaps and breaks (D), dicentric chromosomes (E) and complex chromosome aberrations (F) were scored. *P < 0.05; **P < 0.01; ***P < 0.001.CC BY-NC · PubMed Central
Figure 3. The role of p21 in the maintenance of chromosome stability is independent of the G1-S checkpoint. (A–C) HCT116 wild-type, p21−/− and p53−/− cells were incubated in the absence or presence of MMC for 16 h, and chromosome gaps and breaks (A), dicentric chromosomes (B) and complex chromosome aberrations (C) were scored. (D–F) HCT116 wild-type, p21−/− and p53−/− cells were synchronized via double-thymidine block, released into thymidine-free medium, and treated with 0, 10 and 20 nM MMC for 11 h. Metaphase chromosome gaps and breaks (D), dicentric chromosomes (E) and complex chromosome aberrations (F) were then scored. AS, asynchronous; Synch., synchronous. *P < 0.05; **P < 0.01; ***P < 0.001. (G) Whole-cell lysates were prepared from wild-type, p21−/− and p53−/− cells and immunoblotted with anti-p53, anti-21 and anti-α-tubulin antibodies. The asterisk denotes a non-specific band.
Figure 3. The role of p21 in the maintenance of chromosome stability is independent of the G1-S checkpoint. (A–C) HCT116 wild-type, p21−/− and p53−/− cells were incubated in the absence or presence of MMC for 16 h, and chromosome gaps and breaks (A), dicentric chromosomes (B) and complex chromosome aberrations (C) were scored. (D–F) HCT116 wild-type, p21−/− and p53−/− cells were synchronized via double-thymidine block, released into thymidine-free medium, and treated with 0, 10 and 20 nM MMC for 11 h. Metaphase chromosome gaps and breaks (D), dicentric chromosomes (E) and complex chromosome aberrations (F) were then scored. AS, asynchronous; Synch., synchronous. *P < 0.05; **P < 0.01; ***P < 0.001. (G) Whole-cell lysates were prepared from wild-type, p21−/− and p53−/− cells and immunoblotted with anti-p53, anti-21 and anti-α-tubulin antibodies. The asterisk denotes a non-specific band.CC BY-NC · PubMed Central
Figure 4. An increased phosphorylation of DNA-PKCS S2056 in p21-deficient cells. (A–C) HCT116 p21+/+ and p21−/− cells were incubated in the absence or presence of 10, 20 and 40 nM MMC for 16 h. (A and B) The number of nuclei displaying >5 discrete DNA-PKCS pS2056 foci were quantified using immunofluorescence microscopy and plotted. Representative images of DNA-PKCS pS2056 nuclear foci are shown in (A). At least 300 nuclei were scored per treatment per experiment, and this experiment was performed at least three times with similar results. Error bars represent standard errors of the means from three independent experiments. *P < 0.05; **P < 0.01; ***P < 0.001. (C) Whole-cell lysates were prepared, and resolved proteins were immunoblotted with anti-DNA-PKCS pS2056, anti-DNA-PKCS, anti-p21 and anti-α-tubulin antibodies. The asterisk denotes a non-specific band.
Figure 4. An increased phosphorylation of DNA-PKCS S2056 in p21-deficient cells. (A–C) HCT116 p21+/+ and p21−/− cells were incubated in the absence or presence of 10, 20 and 40 nM MMC for 16 h. (A and B) The number of nuclei displaying >5 discrete DNA-PKCS pS2056 foci were quantified using immunofluorescence microscopy and plotted. Representative images of DNA-PKCS pS2056 nuclear foci are shown in (A). At least 300 nuclei were scored per treatment per experiment, and this experiment was performed at least three times with similar results. Error bars represent standard errors of the means from three independent experiments. *P < 0.05; **P < 0.01; ***P < 0.001. (C) Whole-cell lysates were prepared, and resolved proteins were immunoblotted with anti-DNA-PKCS pS2056, anti-DNA-PKCS, anti-p21 and anti-α-tubulin antibodies. The asterisk denotes a non-specific band.CC BY-NC · PubMed Central
Figure 5. Impaired DNA replication-coupled homologous recombination in p21−/− cells. HCT116 p21+/+ and p21−/− cells were incubated in the presence of bromodeoxyuridine for two cell cycles and in the absence or presence of mitomycin C (A), camptothecin (B) or etoposide (C) for the second cell cycle period. Metaphase spreads were prepared, and the numbers of SCEs were scored. Error bars represent the standard errors of the means. At least 30 metaphases were scored per treatment per experiment. (D) HR reporter assay for the measurement of replication-dependent HR repair of a site-specific DNA ICL (9). (E) p21+/+ and p21−/− cells were transiently transfected with the TR-OriP-GFP vector alone (OriP), TR-OriP-GFP without an ICL (TFO) and psoralen-UVA crosslinked TR-OriP-GFP (pso-TFO), in the presence of EBNA1. Error bars represent standard errors of the means from three independent experiments.*P < 0.05; **P < 0.01; ***P < 0.001.
Figure 5. Impaired DNA replication-coupled homologous recombination in p21−/− cells. HCT116 p21+/+ and p21−/− cells were incubated in the presence of bromodeoxyuridine for two cell cycles and in the absence or presence of mitomycin C (A), camptothecin (B) or etoposide (C) for the second cell cycle period. Metaphase spreads were prepared, and the numbers of SCEs were scored. Error bars represent the standard errors of the means. At least 30 metaphases were scored per treatment per experiment. (D) HR reporter assay for the measurement of replication-dependent HR repair of a site-specific DNA ICL (9). (E) p21+/+ and p21−/− cells were transiently transfected with the TR-OriP-GFP vector alone (OriP), TR-OriP-GFP without an ICL (TFO) and psoralen-UVA crosslinked TR-OriP-GFP (pso-TFO), in the presence of EBNA1. Error bars represent standard errors of the means from three independent experiments.*P < 0.05; **P < 0.01; ***P < 0.001.CC BY-NC · PubMed Central
Figure 6. Elevated MRE11 nuclease activity contributes to the increased chromosome instability of p21−/− cells. (A–C) HCT116 wild-type, p21−/− and p53−/− cells were incubated in the absence or presence of 10, 20 and 40 nM MMC for 16 h. (A and B) The number of nuclei displaying >5 discrete MRE11 foci were quantified using immunofluorescence microscopy and plotted. Representative images of MRE11 nuclear foci are shown in (A). At least 300 nuclei were scored per treatment per experiment, and this experiment was performed at least three times with similar results. (C) Whole-cell lysates were prepared and resolved proteins were immunoblotted with anti-MRE11 and anti-α-tubulin antibodies. (D–F) p21−/− cells were incubated in the absence or presence of 20 nM MMC and 5 and 10 µM mirin for 16 h. Metaphase spreads were prepared, and chromosome aberrations, including gaps and breaks (D), dicentric chromosomes (E) and complex aberrations (F), including radial formations, were scored. At least 80 metaphases were scored per treatment, and this experiment was repeated twice with similar findings. Error bars represent standard errors of the means. *P < 0.05; **P < 0.01; ***P < 0.001.
Figure 6. Elevated MRE11 nuclease activity contributes to the increased chromosome instability of p21−/− cells. (A–C) HCT116 wild-type, p21−/− and p53−/− cells were incubated in the absence or presence of 10, 20 and 40 nM MMC for 16 h. (A and B) The number of nuclei displaying >5 discrete MRE11 foci were quantified using immunofluorescence microscopy and plotted. Representative images of MRE11 nuclear foci are shown in (A). At least 300 nuclei were scored per treatment per experiment, and this experiment was performed at least three times with similar results. (C) Whole-cell lysates were prepared and resolved proteins were immunoblotted with anti-MRE11 and anti-α-tubulin antibodies. (D–F) p21−/− cells were incubated in the absence or presence of 20 nM MMC and 5 and 10 µM mirin for 16 h. Metaphase spreads were prepared, and chromosome aberrations, including gaps and breaks (D), dicentric chromosomes (E) and complex aberrations (F), including radial formations, were scored. At least 80 metaphases were scored per treatment, and this experiment was repeated twice with similar findings. Error bars represent standard errors of the means. *P < 0.05; **P < 0.01; ***P < 0.001.CC BY-NC · PubMed Central
Figure 7. An increased CDK-mediated BRCA2 S3291 phosphorylation in p21−/− cells. (A and B) HCT116 p21+/+ and p21−/− cells were incubated in the absence or presence of 20 or 40 nM MMC for 16 h. Whole-cell lysates were prepared, and resolved proteins were immunoblotted with anti-BRCA2, anti-BRCA2 pS3291 and anti-lamin A antibodies. (B) Band intensities from (A) were quantified using ImageJ and the ratios of BRCA2 pS3291 to BRCA2 plotted. (C and D) p21−/− cells were incubated in the absence or presence of 10 and 20 nM MMC and 3 µM roscovitine (Rosc.) for 16 h. Metaphase spreads were prepared, and chromosome aberrations, including gaps and breaks (C) and complex chromosome aberrations (D), including radial formations, were scored. At least 80 metaphases were scored per treatment, and this experiment was repeated twice with similar findings. Error bars represent standard errors of the means. *P < 0.05; **P < 0.01; ***P < 0.001.
Figure 7. An increased CDK-mediated BRCA2 S3291 phosphorylation in p21−/− cells. (A and B) HCT116 p21+/+ and p21−/− cells were incubated in the absence or presence of 20 or 40 nM MMC for 16 h. Whole-cell lysates were prepared, and resolved proteins were immunoblotted with anti-BRCA2, anti-BRCA2 pS3291 and anti-lamin A antibodies. (B) Band intensities from (A) were quantified using ImageJ and the ratios of BRCA2 pS3291 to BRCA2 plotted. (C and D) p21−/− cells were incubated in the absence or presence of 10 and 20 nM MMC and 3 µM roscovitine (Rosc.) for 16 h. Metaphase spreads were prepared, and chromosome aberrations, including gaps and breaks (C) and complex chromosome aberrations (D), including radial formations, were scored. At least 80 metaphases were scored per treatment, and this experiment was repeated twice with similar findings. Error bars represent standard errors of the means. *P < 0.05; **P < 0.01; ***P < 0.001.CC BY-NC · PubMed Central
Figure 8. Proposed model for the role of p21 in replication-coupled DNA double-strand break repair. Following exposure to DNA-damaging agents that block DNA replication fork progression, p21 physically binds to, and inhibits, CDK, thereby preventing phosphorylation of BRCA2 on S3291. RAD51 nucleoprotein filaments assemble on ssDNA and are stabilized through interaction with the unphosphorylated carboxy-terminus of BRCA2, thereby promoting HR repair. In the absence of p21, unrestricted CDK activity leads to the constitutive phosphorylation of BRCA2 on S3291. S3291 phosphorylation precludes binding of RAD51 to the carboxy-terminus of BRCA2, resulting in destabilization of RAD51 nucleoprotein filaments. Deprotected ssDNA now becomes susceptible to opportunistic and inadvertent MRE11 nuclease activity, leading to increased error-prone NHEJ and chromosome instability.
Figure 8. Proposed model for the role of p21 in replication-coupled DNA double-strand break repair. Following exposure to DNA-damaging agents that block DNA replication fork progression, p21 physically binds to, and inhibits, CDK, thereby preventing phosphorylation of BRCA2 on S3291. RAD51 nucleoprotein filaments assemble on ssDNA and are stabilized through interaction with the unphosphorylated carboxy-terminus of BRCA2, thereby promoting HR repair. In the absence of p21, unrestricted CDK activity leads to the constitutive phosphorylation of BRCA2 on S3291. S3291 phosphorylation precludes binding of RAD51 to the carboxy-terminus of BRCA2, resulting in destabilization of RAD51 nucleoprotein filaments. Deprotected ssDNA now becomes susceptible to opportunistic and inadvertent MRE11 nuclease activity, leading to increased error-prone NHEJ and chromosome instability.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 38 references

Cited by

See all 59

Metadata

Authors
Mauro, M., Rego, M. A., Boisvert, R. A., Esashi, F., Cavallo, F., Jasin, M., & Howlett, N. G.
Affiliations
Memorial Sloan Kettering Cancer Center (US)
Corresponding author
Howlett, Niall G.
Venue
Nucleic Acids Research
Published
2012-06-25
Volume
40
Issue
17
Pages
8348-8360
ISSN
  • 0305-1048 (ISSN-L)
  • 1362-4962
OpenAlex
W2101230738
Cited by
56
References
41
Citations by year
2026: 1 · 2025: 4 · 2024: 4 · 2023: 2 · 2022: 4 · 2021: 4 · 2020: 7 · 2019: 5 · 2018: 5 · 2017: 4 · 2016: 2 · 2015: 3 · 2014: 7 · 2013: 4
FWCI
1.80
Type
journal article
Language
en
Open access
Locations
  • Nucleic Acids Research (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Journal of Media Literacy Education (submittedVersion, cc-by-nc)
  • HighWire Press Open Archive (submittedVersion)
Funders
  • National Science Foundation (1004057)
  • Wellcome Trust (101009)
  • National Institutes of Health
  • National Heart, Lung, and Blood Institute (R01HL101977, R21HL095991)
  • National Center for Research Resources (P20RR016457)
  • Office of Experimental Program to Stimulate Competitive Research (1004057)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
  • Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy
Keywords
p21, DNA double-strand break repair, homologous recombination, non-homologous end joining, DNA-PKcs phosphorylation, MRE11, cyclin-dependent kinases, sister chromatid exchange, chromosome stability, chromatid aberrations, DNA damage hypersensitivity
MeSH terms
MRE11 Homologue Protein, Animals, Camptothecin, Cross-Linking Reagents, DNA Repair, DNA Replication, DNA-Binding Proteins, Etoposide, HeLa Cells, Humans, Phosphorylation, Mitomycin, BRCA2 Protein, Chromosomal Instability, HCT116 Cells, DNA Repair Enzymes, Cyclin-Dependent Kinase Inhibitor p21, Mice, DNA Breaks, Double-Stranded, Topoisomerase Inhibitors, G1 Phase Cell Cycle Checkpoints, DNA End-Joining Repair, Recombinational DNA Repair

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: p21 promotes error-free replication-coupled DNA double-strand break repair. https://app.cochat.ai/papers/10.1093/nar/gks612
The paper
Mauro, M., Rego, M. A., Boisvert, R. A., Esashi, F., Cavallo, F., Jasin, M., & Howlett, N. G. (2012). p21 promotes error-free replication-coupled DNA double-strand break repair. Nucleic Acids Research. https://doi.org/10.1093/nar/gks612

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.